Met Life Investment Management, LLC Generation Bio Co. Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Generation Bio Co. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 4,304 shares of GBIO stock, worth $4,045. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,304
Previous 28,396
84.84%
Holding current value
$4,045
Previous $80,000
87.5%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding GBIO
# of Institutions
74Shares Held
49.6MCall Options Held
0Put Options Held
0-
Price T Rowe Associates Inc Baltimore, MD9.35MShares$8.79 Million0.0% of portfolio
-
Atlas Venture Life Science Advisors, LLC8.28MShares$7.78 Million2.52% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.92MShares$3.68 Million0.16% of portfolio
-
Black Rock Inc. New York, NY3.29MShares$3.1 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC2.98MShares$2.8 Million0.0% of portfolio
About Generation Bio Co.
- Ticker GBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,011,200
- Market Cap $55.5M
- Description
- Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...